MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-08-0003371
Market Cap
₹6.00 Cr
DLCL · BSE
Share Price
₹6.69
-3.74% today
Revenue
₹4.19 Cr
FY 2025-26 · -5.8% YoY
EBITDA
₹0.69 Cr
Margin 16.5%
Net Profit
₹0.07 Cr
FY 2025-26 · -75.9% YoY
P/E (TTM)
94.5x
P/B 0.4x
Authorised capital
₹11 Cr
Registered with MCA
Paid-up capital
₹8.64 Cr
Issued & subscribed
About Dr Lalchandani Labs Limited
Data last updated:
Dr Lalchandani Labs Limited is a public limited company based in New Delhi, Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 02 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L85320DL2017PLC321605. It is a listed company as per MCA records. Its shares are listed on BSE: 541299.
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹8.64 Cr. It is led by directors including Arjan Lal Chandani (Managing Director) and Mohit Lal Chandani (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at M – 20 Basement Greater Kailash – 1, New Delhi, Delhi, India – 110048.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹4.19 Cr, a decline of 5.8% compared to the previous year. For the same year it recorded a net profit of ₹7 Lakh (net margin 1.7%) and EBITDA of ₹69 Lakh (EBITDA margin 16.5%).
The company has about 14 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Dr Lalchandani Labs. As per MCA filings, the company has open charges of ₹2.64 Cr and satisfied charges of ₹1.2 Cr on record. Court records list 22 cases involving the company, including 3 filed by the company and 19 filed against it; 8 cases are pending. The company has 64 deals on record (63 market trades, 1 ipo); the latest was in September 2026. The company has 7 MSME Form 1 returns on record between 2019 and 2022, listing 388 overdue payments to 19 micro and small suppliers.
Dr Lalchandani Labs Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0003371). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lalchandanipathlab.com.
Company details
CIN L85320DL2017PLC321605
Registration Number 321605
Incorporation Date 02 August 2017
ROC Delhi
Listing Status Listed - Listed on BSE (541299)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-08-0003371
CIN history
Dr Lalchandani Labs has one previous CIN (Corporate Identification Number): U85320DL2017PLC321605. The current CIN is L85320DL2017PLC321605, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85320DL2017PLC321605 | Current |
| U85320DL2017PLC321605 | Previous |
Key People
Arjan Lal Chandani Managing Director Mohit Lal Chandani Whole-Time Director Anchal Gupta Director Recognitions & Rankings of Dr Lalchandani Labs
Contact details
Dr Lalchandani Labs Limited's registered office is in New Delhi, Delhi. Its website is lalchandanipathlab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressM – 20 Basement Greater Kailash – 1, New Delhi, Delhi, India – 110048
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Dr Lalchandani Labs Limited, buy the company report.
Comprehensive company report
Dr Lalchandani Labs Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Dr Lalchandani Labs operates one associated brand: Dr Lalchandani Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers pathology, radiology, and health checkup services with home collection. | lalchandanipathlab.com |
Business activity
The main business activity of Dr Lalchandani Labs is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Dr Lalchandani Labs Limited, buy the company report.
Financials of Dr Lalchandani Labs Limited
FY 2025-26 filings availableDr Lalchandani Labs Limited reported revenue of ₹4.19 Cr (down 5.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹4.19 Cr
-5.8% YoY
EBITDA
₹0.69 Cr
-25.0% YoY
Profit After Tax
₹0.07 Cr
-75.9% YoY
Net Worth
-
Total Assets
-
Total Debt
-
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 4.19 | 4.45 | 4.81 | 5.04 | 11.28 | 9.78 | 6.10 |
| Revenue growth | -5.8% | -7.5% | -4.6% | -55.3% | +15.3% | +60.3% | - |
| EBITDA | 0.69 | 0.92 | 0.19 | 0.09 | 2.46 | 2.24 | 1.26 |
| EBITDA margin | +16.5% | +20.7% | +4.0% | +1.8% | +21.8% | +22.9% | +20.7% |
| Profit before tax | 0.10 | 0.40 | 0.62 | (1.56) | 1.27 | 1.37 | 0.66 |
| Net profit | 0.07 | 0.29 | (0.76) | (1.56) | 0.91 | 1.01 | 0.47 |
| Net profit margin | +1.7% | +6.5% | -15.8% | -31.0% | +8.1% | +10.3% | +7.7% |
| EPS (₹) | 0.07 | 0.96 | 1.43 | (3.61) | 2.15 | 2.33 | 1.09 |
| Balance sheet | |||||||
| Total assets | - | 14.02 | 13.02 | 15.33 | 15.63 | 13.59 | 10.30 |
| Net worth | - | 9.95 | 9.54 | 8.92 | 10.48 | 9.55 | 8.54 |
| Total debt | - | 4.07 | 3.48 | 6.40 | 5.15 | 4.04 | 1.76 |
| Cash & bank | - | 3.30 | 2.29 | 3.10 | 3.53 | 2.89 | 2.25 |
| Net working capital | - | 9.27 | 7.67 | 8.79 | 8.47 | 7.09 | 6.00 |
| Cash flow | |||||||
| Cash from operations | - | 0.37 | (0.22) | 0.00 | 2.01 | 1.19 | (0.10) |
| Cash from investing | - | 0.06 | 1.00 | (0.20) | (1.53) | (2.26) | (0.53) |
| Cash from financing | - | 0.58 | (1.59) | (0.23) | 0.16 | 1.71 | 0.85 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 03 Nov 2026
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.19 | 4.45 | 4.81 | 5.04 | 11.28 | 9.78 | 6.10 |
| Revenue growth | -5.8% | -7.5% | -4.6% | -55.3% | +15.3% | +60.3% | - |
| Other income | 0.00 | 0.13 | 1.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total expenses | 3.50 | 3.53 | 4.62 | 4.95 | 8.82 | 7.54 | 4.84 |
| Employee cost | 0.00 | 0.48 | 0.72 | 1.11 | 1.11 | 0.42 | 0.57 |
| EBITDA | 0.69 | 0.92 | 0.19 | 0.09 | 2.46 | 2.24 | 1.26 |
| EBITDA margin | +16.5% | +20.7% | +4.0% | +1.8% | +21.8% | +22.9% | +20.7% |
| Depreciation | 0.57 | 0.56 | 0.62 | 0.66 | 0.59 | 0.52 | 0.42 |
| Interest | 0.02 | 0.09 | 0.38 | 0.99 | 0.60 | 0.35 | 0.18 |
| Profit before tax | 0.10 | 0.40 | 0.62 | (1.56) | 1.27 | 1.37 | 0.66 |
| Tax | 0.03 | (0.01) | 0.00 | 0.00 | 0.36 | 0.36 | 0.19 |
| Net profit | 0.07 | 0.29 | (0.76) | (1.56) | 0.91 | 1.01 | 0.47 |
| Net profit margin | +1.7% | +6.5% | -15.8% | -31.0% | +8.1% | +10.3% | +7.7% |
| EPS (₹) | 0.07 | 0.96 | 1.43 | (3.61) | 2.15 | 2.33 | 1.09 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 4.33 | 4.33 | 4.33 | 4.33 | 4.33 | 4.33 |
| Reserves & surplus | - | 5.62 | 5.21 | 4.59 | 6.15 | 5.22 | 4.21 |
| Shareholders' funds (net worth) | - | 9.95 | 9.54 | 8.92 | 10.48 | 9.55 | 8.54 |
| Secured loans | - | 0.00 | 0.00 | 1.21 | 1.43 | 1.62 | 0.97 |
| Unsecured loans | - | 4.07 | 3.48 | 5.19 | 3.72 | 2.42 | 0.79 |
| Total debt | - | 4.07 | 3.48 | 6.40 | 5.15 | 4.04 | 1.76 |
| Total liabilities | - | 14.02 | 13.02 | 15.33 | 15.63 | 13.59 | 10.30 |
| Assets | |||||||
| Gross block | - | 7.35 | 7.27 | 8.05 | 7.74 | 6.65 | 4.35 |
| Net block | - | 3.51 | 3.99 | 5.40 | 5.75 | 5.25 | 3.47 |
| Capital work in progress | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | - | 0.27 | 0.41 | 0.24 | 0.24 | 0.24 | 0.24 |
| Inventories | - | 1.29 | 1.44 | 1.52 | 1.56 | 0.68 | 0.50 |
| Sundry debtors | - | 5.26 | 4.70 | 4.97 | 4.22 | 3.98 | 3.33 |
| Cash & bank balances | - | 3.30 | 2.29 | 3.10 | 3.53 | 2.89 | 2.25 |
| Loans & advances | - | 1.02 | 1.05 | 1.43 | 1.50 | 1.01 | 1.48 |
| Total current assets | - | 10.87 | 9.48 | 11.02 | 10.81 | 8.56 | 7.56 |
| Total current liabilities | - | 1.60 | 1.81 | 2.23 | 2.34 | 1.47 | 1.56 |
| Net working capital | - | 9.27 | 7.67 | 8.79 | 8.47 | 7.09 | 6.00 |
| Total assets | - | 14.02 | 13.02 | 15.33 | 15.63 | 13.59 | 10.30 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 2.29 | 3.10 | 3.53 | 2.89 | 2.25 | 2.02 |
| Net cash from operating activities | - | 0.37 | (0.22) | 0.00 | 2.01 | 1.19 | (0.10) |
| Net cash from investing activities | - | 0.06 | 1.00 | (0.20) | (1.53) | (2.26) | (0.53) |
| Net cash from financing activities | - | 0.58 | (1.59) | (0.23) | 0.16 | 1.71 | 0.85 |
| Net change in cash | - | 1.01 | (0.81) | (0.43) | 0.64 | 0.64 | 0.23 |
| Closing cash | - | 3.30 | 2.29 | 3.10 | 3.53 | 2.89 | 2.25 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -5.8% | -7.5% | -4.6% | -55.3% | +15.3% | +60.3% | - |
| EBITDA growth | -25.0% | +384.2% | +111.1% | -96.3% | +9.8% | +77.8% | - |
| PBT growth | -75.0% | -35.5% | +9998.0% | - | -7.3% | +107.6% | -8.3% |
| Net income growth | -75.9% | +138.2% | +51.3% | -271.4% | -9.9% | +114.9% | - |
| Revenue CAGR (3Y) | -6.0% | -26.7% | -21.1% | -6.2% | +29.0% | +51.9% | +44.3% |
| EBITDA CAGR (3Y) | +97.2% | -28.0% | -56.1% | -58.5% | +27.0% | +52.6% | +33.5% |
| Profitability & leverage | |||||||
| Net income margin | +1.7% | +9.2% | +12.9% | -31.0% | +8.1% | +10.3% | +7.7% |
| Return on capital employed | - | +2.7% | -2.7% | -3.7% | +12.9% | +14.5% | +8.7% |
| Return on net worth | - | +3.1% | -8.2% | -16.1% | +9.3% | +11.2% | +5.7% |
| Debt / equity | - | 0.39 | 0.54 | 0.60 | 0.46 | 0.32 | 0.16 |
| Long-term debt / equity | - | 0.01 | 0.19 | 0.31 | 0.26 | 0.23 | 0.12 |
| Interest cover | 16.67 | 25.00 | -88.37 | -173.68 | 32.09 | 20.35 | 21.43 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.61 | 0.63 | 0.64 | 1.57 | 1.78 | 1.51 |
| Inventory turnover | - | 3.26 | 3.25 | 3.27 | 10.07 | 16.58 | 13.71 |
| Debtors turnover | - | 0.89 | 0.99 | 1.10 | 2.75 | 2.68 | 2.36 |
| EPS (₹) | 0.07 | 0.96 | 1.43 | (3.61) | 2.15 | 2.33 | 1.09 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 22.98 | 22.02 | 20.59 | 24.16 | 22.01 | 19.68 |
To see the full year-wise statements and ratios of Dr Lalchandani Labs Limited, buy the company report.
Board of directors of Dr Lalchandani Labs Limited
Dr Lalchandani Labs has 6 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohit Lal Chandani | Whole-Time Director | 02 Aug 2017 | 9 Years 3 Months | Current |
| Arjan Lal Chandani | Managing Director | 02 Aug 2017 | 9 Years 3 Months | Current |
| Anchal Gupta | Director | 02 Aug 2017 | 9 Years 3 Months | Current |
| Rajiv Handa | Director | 27 Dec 2017 | 8 Years 10 Months | Current |
| Swati Chandra | Director | 09 Mar 2022 | 4 Years 7 Months | Current |
| Mohan Lal Gandhi Also directs: Dukaan Resources Private Limited | Director | 30 Sep 2025 | 1 Years 1 Months | Current |
Auditor
Dr Lalchandani Labs Limited is audited by Jain Agarwal & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Jain Agarwal & Company | FY 2023 | 024866N |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 32.90%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 67.10%.
Sep 2026
QUARTER
32.90% Promoters
67.10% Retail & Others
Promoter holding - history
Now 32.90% · Sep 2026High 48.30% · Dec 2025Low 31.20% · Jun 2026
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 32.90% | 31.20% | 48.30% | 48.30% |
| Public | 67.10% | 68.80% | 51.70% | 51.70% |
Charges & borrowings
Open charges
₹2.64 Cr
Satisfied charges
₹1.2 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Nov 2020 | 100391926 | Others | ₹2.64 Cr | Open | |
| 14 Aug 2019 | 100280929 | Others | ₹1 Cr | Satisfied | |
| 29 Jun 2019 | 100277118 | Others | ₹20 Lakh | Satisfied |
To see the full charge records of Dr Lalchandani Labs Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Dr Lalchandani Labs Limited has 64 deals on record (63 market trades, 1 ipo); the latest was in September 2026.
Total deals
64
Market trades
63
IPO
1
Deals on record (5 of 64)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2025 | Market trade | ₹8.5 Lakh | Buyer: an individual Seller: Multiplier Share and Stock Advisors Private Limited |
| Mar 2025 | Market trade | ₹20.1 Lakh | Buyer: Soham Fincare India LLP , 2 individuals Seller: Soham Fincare India LLP , an individual |
| Dec 2022 | Market trade | ₹13.4 Lakh | Buyer: Mithun Securities Private Limited |
| Apr 2021 | Market trade | ₹13.3 Lakh | Buyer: NNM Securities Private Limited Seller: NNM Securities Private Limited |
| Apr 2021 | Market trade | ₹10.5 Lakh | Buyer: NNM Securities Private Limited Seller: NNM Securities Private Limited , Frontline Securities Limited |
To see the full deal history of Dr Lalchandani Labs Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Dr Lalchandani Labs Limited has 22 court cases on record: 3 filed by Dr Lalchandani Labs, 19 filed against it. 8 cases are pending and 14 are disposed.
Total cases
22
Filed by the company
3
Filed against the company
19
Pending
8
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 20 | 18 | 8 |
| High courts | 2 | 1 | 0 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Civil suit | Filed against the company by Dr Meditech Surgical Diagnostics India Pvt Ltd | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by M/S. Kisetsu Saison Finance India Private Limited Rep. by Senior Manager Legal Ms. Disha Chandra S | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed against the company by M/S Clix Capital Services Pvt. Ltd. | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Kotak Mahindra Bank Ltd | Disposed |
| District court, South, Delhi | Interim or miscellaneous application | Filed against the company by Hero Fincorp Ltd. and 1 other | Disposed |
To see the full case history of Dr Lalchandani Labs Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Dr Lalchandani Labs Limited has 7 MSME Form 1 returns on record between 2019 and 2022, listing 388 overdue payments to 19 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 19)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Tricog Health India Private Limited | |||
| Proactive Healthcare Private Limited | |||
| Goodwill Diagnostics | |||
| Dr Meditech Surgical and Diagnostics (India) Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Dr Lalchandani Labs Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Dr Lalchandani Labs Limited has a workforce of 14 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
14
Active EPFO establishments
1
Employee growth
16.67%
GST
No GST registration is on our record for Dr Lalchandani Labs Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dr Lalchandani Labs Limited has 16 board changes on record since 2017: 11 appointments and 5 cessations. The latest: Mohan Lal Gandhi was appointed as Director on 30 Sep 2025.
Filing
Dr Lalchandani Labs Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi I.
AGM
Dr Lalchandani Labs Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Mohan Lal Gandhi was appointed as Director.
Ceased
Prakash Jhuraney ceased to be Director.
Ceased
Karan Kumar ceased to be Company Secretary.
Appointed
Karan Kumar was appointed as Company Secretary.
Appointed
Swati Chandra was appointed as Director.
Ceased
Manica Gupta ceased to be Director.
Charges
A charge with Others of Rs. 2.64 Cr registered on 04 Nov 2020 with Charge ID 100391926 was modified on 28 Jul 2021.
Charges
A charge registered on 29 Jun 2019 via Charge ID 100277118 with Others was fully satisfied on 18 May 2021.
Charges
A charge registered on 14 Aug 2019 via Charge ID 100280929 with Others was fully satisfied on 23 Nov 2020.
Charges
A charge with Others amounted to Rs. 2.64 Cr with Charge ID 100391926 was registered on 04 Nov 2020.
13 earlier events are in the company report.
News
Frequently asked questions
Dr Lalchandani Labs is an active public limited company based in New Delhi, Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 02 August 2017 (9+ years old) and is registered under CIN L85320DL2017PLC321605. Listed on BSE: 541299.
Dr Lalchandani Labs reported revenue of ₹4.19 Cr for FY 2025-26 (down 5.8% YoY) based on standalone financials.
Dr Lalchandani Labs has 6 current directors:
- Arjan Lal Chandani - Managing Director
- Mohit Lal Chandani - Whole-Time Director
- Anchal Gupta - Director
- Rajiv Handa - Director
- Swati Chandra - Director
- Mohan Lal Gandhi - Director
The latest financial statements of Dr Lalchandani Labs on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Dr Lalchandani Labs is L85320DL2017PLC321605. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Dr Lalchandani Labs is a listed company as per MCA records. Its shares are listed on BSE (code: 541299).
Dr Lalchandani Labs has 22 court cases on record: 3 filed by the company and 19 filed against it. 8 are pending. Most are in the district courts.
Dr Lalchandani Labs was incorporated on 02 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Dr Lalchandani Labs has 64 deals on record (63 market trades, 1 ipo); the latest was in September 2026.
Mohan Lal Gandhi was appointed as Director on 30 Sep 2025. Prakash Jhuraney ceased to be Director on 05 Sep 2025. Karan Kumar ceased to be Company Secretary on 06 Apr 2024. Dr Lalchandani Labs has 16 board changes on record in total.
Yes, Dr Lalchandani Labs is registered as a small enterprise under Udyam registration (number: UDYAM-DL-08-0003371).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages